Company intelligence / Profile preview

Heliconia Capital

Singapore, Singapore

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Heliconia Capital is a Singapore-based investment firm and subsidiary of Temasek that provides growth capital to SMEs in Singapore and Southeast Asia across multiple sectors, including healthcare and biotechnology, but it is not itself a life science/biotech company.[5][6][9][1]

Industry: Investors

Partnerships

Portfolio and strategic investments in healthcare providers and health/biotech companies such as HMI Group (Health Management International), Lucence Health, Tessa Therapeutics and other Singapore and ASEAN SMEs, typically as a financial/strategic investor rather than an operating partner.[1][2][4][6]

Beyond the preview

Go deeper on Heliconia Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heliconia Capital.

Explore the full profile